top of page

๐—œ๐—ฅ๐—”๐—ฃ: ๐—ง๐—ต๐—ฒ ๐—”๐—ป๐˜๐—ถ-๐—œ๐—ป๐—ณ๐—น๐—ฎ๐—บ๐—บ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—˜๐˜ƒ๐—ฒ๐—ฟ๐˜†๐—ผ๐—ป๐—ฒโ€™๐˜€ ๐—ง๐—ฎ๐—น๐—ธ๐—ถ๐—ป๐—ด ๐—”๐—ฏ๐—ผ๐˜‚๐˜ (๐—”๐—ด๐—ฎ๐—ถ๐—ป)

  • kparmstrong1
  • Jan 8
  • 2 min read

If youโ€™ve been around orthobiologics, youโ€™ve heard of ๐—œ๐—ฅ๐—”๐—ฃ โ€” ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—น๐—ฒ๐˜‚๐—ธ๐—ถ๐—ป-๐Ÿญ ๐—ฅ๐—ฒ๐—ฐ๐—ฒ๐—ฝ๐˜๐—ผ๐—ฟ ๐—”๐—ป๐˜๐—ฎ๐—ด๐—ผ๐—ป๐—ถ๐˜€๐˜ ๐—ฃ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป.



Its job: block ๐—œ๐—Ÿ-๐Ÿญ, the cytokine that drives joint inflammation and cartilage loss.



When IL-1 is blocked by ๐—œ๐—Ÿ-๐Ÿญ๐—ฅ๐—ฎ, inflammation cools โ€” often dramatically.



๐—ช๐—ต๐—ฒ๐—ฟ๐—ฒ ๐—œ๐˜ ๐—ฆ๐˜๐—ฎ๐—ฟ๐˜๐—ฒ๐—ฑ


In the early 2000s, ๐——๐—ฟ. ๐—ฃ๐—ฒ๐˜๐—ฒ๐—ฟ ๐—ช๐—ฒ๐—ต๐—น๐—ถ๐—ป๐—ด (Germany) discovered that incubating blood with treated glass beads triggered white cells to release ๐Ÿฎ๐Ÿฌโ€“๐Ÿฑ๐Ÿฌร— ๐—บ๐—ผ๐—ฟ๐—ฒ ๐—œ๐—Ÿ-๐Ÿญ๐—ฅ๐—ฎ.



That conditioned serum became ๐—ข๐—ฟ๐˜๐—ต๐—ผ๐—ธ๐—ถ๐—ป๐—ฒยฎ / ๐—ฅ๐—ฒ๐—ด๐—ฒ๐—ป๐—ผ๐—ธ๐—ถ๐—ป๐—ฒยฎ, the first IRAP-type therapy.



๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฅ๐—ฒ๐—ฎ๐—น๐—ถ๐˜๐˜† (๐—จ.๐—ฆ.)


From what we can tell, those original bead-based ACS/IRAP systems are ๐—ป๐—ผ๐˜ ๐—™๐——๐—”-๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—ฒ๐—ฑ ๐—ผ๐—ฟ ๐—ฎ๐—ฝ๐—ฝ๐—ฟ๐—ผ๐˜ƒ๐—ฒ๐—ฑ and remain primarily available overseas.



Some newer โ€œ๐—”๐—ฃ๐—ฆโ€ systems aim for a same-day protein-rich plasma using ๐—ฐ๐—น๐—ผ๐˜€๐—ฒ๐—ฑ ๐—ฃ๐—ฅ๐—ฃ-๐—น๐—ถ๐—ธ๐—ฒ ๐—ฑ๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€, but intra-articular APS use for OA still appears ๐—ถ๐—ป๐˜ƒ๐—ฒ๐˜€๐˜๐—ถ๐—ด๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—จ.๐—ฆ.



๐—ช๐—ต๐˜† ๐—œ๐˜โ€™๐˜€ ๐—•๐—ฎ๐—ฐ๐—ธ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ฆ๐—ฝ๐—ผ๐˜๐—น๐—ถ๐—ด๐—ต๐˜


Because ๐—œ๐—Ÿ-๐Ÿญ๐—ฅ๐—ฎ ๐—ถ๐˜€๐—ปโ€™๐˜ ๐—ท๐˜‚๐˜€๐˜ ๐—ฎ๐—ป๐—ผ๐˜๐—ต๐—ฒ๐—ฟ ๐—ด๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐—ณ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ โ€” ๐—ถ๐˜โ€™๐˜€ ๐—ฎ ๐—บ๐—ฎ๐˜€๐˜๐—ฒ๐—ฟ ๐˜€๐˜„๐—ถ๐˜๐—ฐ๐—ต in the inflammatory cascade.



High IL-1Ra levels have been linked with improved ๐—ฝ๐—ฎ๐—ถ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ณ๐˜‚๐—ป๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐˜€๐—ฐ๐—ผ๐—ฟ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ธ๐—ป๐—ฒ๐—ฒ ๐—ข๐—” and protective effects on ๐—ฐ๐—ฎ๐—ฟ๐˜๐—ถ๐—น๐—ฎ๐—ด๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐˜€๐˜†๐—ป๐—ผ๐˜ƒ๐—ถ๐˜‚๐—บ in preclinical models.



๐—ง๐—ต๐—ฒ โ€œ๐—•๐˜‚๐—ณ๐—ผ๐—ฟ๐—ฑ ๐—›๐—ฎ๐—ฐ๐—ธโ€ (https://lnkd.in/gMVWz2yu)



Hereโ€™s the interesting twist:



Dr. ๐——๐—ผ๐—ป ๐—•๐˜‚๐—ณ๐—ผ๐—ฟ๐—ฑ and others point out that ๐—ฏ๐—ผ๐—ป๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ฝ๐—น๐—ฎ๐˜€๐—บ๐—ฎ ๐—ฎ๐—น๐—ฟ๐—ฒ๐—ฎ๐—ฑ๐˜† ๐—ฐ๐—ผ๐—ป๐˜๐—ฎ๐—ถ๐—ป๐˜€ ~๐Ÿฎ๐Ÿฌร— ๐—ต๐—ถ๐—ด๐—ต๐—ฒ๐—ฟ ๐—ฏ๐—ฎ๐˜€๐—ฒ๐—น๐—ถ๐—ป๐—ฒ ๐—œ๐—Ÿ-๐Ÿญ๐—ฅ๐—ฎ than peripheral blood.



So, concentrating and reducing plasma volume from ๐—ฏ๐—ผ๐—ป๐—ฒ ๐—บ๐—ฎ๐—ฟ๐—ฟ๐—ผ๐˜„ ๐—ฎ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ฒ could theoretically reach IRAP-like IL-1Ra levels โ€”


all within ๐˜€๐—ฎ๐—บ๐—ฒ-๐—ฑ๐—ฎ๐˜†, ๐—บ๐—ถ๐—ป๐—ถ๐—บ๐—ฎ๐—น๐—น๐˜† ๐—บ๐—ฎ๐—ป๐—ถ๐—ฝ๐˜‚๐—น๐—ฎ๐˜๐—ฒ๐—ฑ procedures.



Not an โ€œapproved IRAP kitโ€ โ€” but biologically, it makes sense.



๐—•๐—ถ๐—ด ๐—ฃ๐—ถ๐—ฐ๐˜๐˜‚๐—ฟ๐—ฒ


IRAP and its cousins (ACS, APS, BMAC-derived plasma) represent a shift:



๐˜๐˜ณ๐˜ฐ๐˜ฎ ๐˜จ๐˜ณ๐˜ฐ๐˜ธ๐˜ต๐˜ฉ-๐˜ง๐˜ข๐˜ค๐˜ต๐˜ฐ๐˜ณ-๐˜ฅ๐˜ณ๐˜ช๐˜ท๐˜ฆ๐˜ฏ ๐˜ณ๐˜ฆ๐˜จ๐˜ฆ๐˜ฏ๐˜ฆ๐˜ณ๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ โ†’ ๐˜ต๐˜ฐ ๐˜ค๐˜บ๐˜ต๐˜ฐ๐˜ฌ๐˜ช๐˜ฏ๐˜ฆ-๐˜ฅ๐˜ณ๐˜ช๐˜ท๐˜ฆ๐˜ฏ immunomodulation.



Cool the fire first. Then let the joint heal.



๐—ข๐—ฝ๐—ฒ๐—ป ๐—ค๐˜‚๐—ฒ๐˜€๐˜๐—ถ๐—ผ๐—ป:


Is IL-1Ra the next big lever in orthobiologics โ€” or just one more acronym in the alphabet soup?


If youโ€™re using marrow plasma or APS systems, what IL-1Ra levels are you actually seeing?

Activate to view larger image,

Recent Posts

See All
bottom of page